These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12037500)

  • 1. [New developments in somatostatin analogs and their receptors].
    Jaquet P
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 3):2S3-4. PubMed ID: 12037500
    [No Abstract]   [Full Text] [Related]  

  • 2. Somatostatin receptor subtypes: targeting functional and therapeutic specificity.
    Culler MD; Taylor JE; Moreau JP
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 3):2S5-12. PubMed ID: 12037501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of cell proliferation by somatostatin].
    Buscail L; Vernejoul F; Faure P; Torrisani J; Susini C
    Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 3):2S13-8. PubMed ID: 12037498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Symposium on Somatostatin Analogs: Basic Update and Clinical Perspectives. Venice, Italy, October 24-25, 1997. Abstracts.
    J Endocrinol Invest; 1997; 20(7 Suppl):1-106. PubMed ID: 9484527
    [No Abstract]   [Full Text] [Related]  

  • 5. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that a novel somatostatin receptor couples to an inward rectifier potassium current in AtT-20 cells.
    Tallent M; Dichter MA; Reisine T
    Neuroscience; 1996 Aug; 73(3):855-64. PubMed ID: 8809804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drugs interfering with somatostatin receptors].
    Berrino L; Rossi S; Formato P; Vitelli M
    Minerva Endocrinol; 2001 Sep; 26(3):119-21. PubMed ID: 11753233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiotropic effects of somatostatin and its antagonists].
    Osadchiĭ OE; Pokrovskiĭ VM; Matsko MA; Cherednik IL
    Biull Eksp Biol Med; 1997 Sep; 124(9):263-6. PubMed ID: 9445601
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its antiproliferative and antiangiogenic activity in vitro.
    Dasgupta P; Mukherjee R
    Br J Pharmacol; 2000 Jan; 129(1):101-9. PubMed ID: 10694208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of new potential therapeutic applications of somatostatin analogs.
    Pawlikowski M; Melen-Mucha G
    Neuro Endocrinol Lett; 2003; 24(1-2):21-7. PubMed ID: 12743527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action.
    Woltering EA; Watson JC; Alperin-Lea RC; Sharma C; Keenan E; Kurozawa D; Barrie R
    Invest New Drugs; 1997; 15(1):77-86. PubMed ID: 9195291
    [No Abstract]   [Full Text] [Related]  

  • 12. Changing role of somatostatin receptor targeted drugs in NET: Nuclear Medicine's view.
    Prasad V; Fetscher S; Baum RP
    J Pharm Pharm Sci; 2007; 10(2):321s-337s. PubMed ID: 17718935
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vivo and in vitro study of the effect of somatostatin and somatostatin-immunoreactive substance on the histology of the mantle edge in adult and juvenile snails (Helix aspersa)].
    Assaka L; Marchand CR; Baud C
    C R Seances Soc Biol Fil; 1997; 191(4):627-38. PubMed ID: 9404464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for treating cancer with somatostatin analogs.
    Minuto F; Ferone D; Arvigo M; Barreca A
    J Endocrinol Invest; 2003; 26(8 Suppl):117-9. PubMed ID: 15233226
    [No Abstract]   [Full Text] [Related]  

  • 16. Somatostatin-induced control of cytosolic free calcium in pituitary tumour cells.
    Petrucci C; Cervia D; Buzzi M; Biondi C; Bagnoli P
    Br J Pharmacol; 2000 Feb; 129(3):471-84. PubMed ID: 10711345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of somatostatin analogs in the control of tumor growth.
    Lamberts SW; Reubi JC; Krenning EP
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):61-4. PubMed ID: 7992085
    [No Abstract]   [Full Text] [Related]  

  • 18. Somatostatin receptor physiology and targets for somatostatin analogue therapy. Abstracts of the Young Investigator Meeting. 31 October-2 November 2002, Barcelona, Spain.
    Eur J Endocrinol; 2003 Jan; 148 Suppl 1():50 pages. PubMed ID: 12602334
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peptide modulation of vagal sinus arrhythmia in cats].
    Osadchiĭ OE; Pokrovskiĭ VM
    Ross Fiziol Zh Im I M Sechenova; 1997; 83(11-12):122-34. PubMed ID: 9541964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of somatostatin analogs on biochemical parameters in acromegaly.
    Liuzzi A; Marzullo P
    J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.